Efficacy, Safety, and Recurrence Prediction of Minimally Invasive Percutaneous Nephrolithotomy in Uyghur and Han Pediatric Patients with Upper Urinary Tract Calculi
Urologia Internationalis · 2025
DOI: 10.1159/000548385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urologia Internationalis, 2025. Verfasst von Ruiyu Yue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Nephrolithotomy, Percutaneous, Kidney Calculi, Urinary Calculi. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
The aim of the study was to evaluate the efficacy, safety, and recurrence risk of minimally invasive percutaneous nephrolithotomy (PCNL) in Uyghur and Han pediatric patients with upper urinary tract calculi and develop predictive models with nomograms for postoperative recurrence.
Methods
Clinical data from 231 children (159 Uyghur, 72 Han) treated with Mini-PCNL or Microperc between June 2019 and June 2024 were retrospectively reviewed. Recurrence-free survival was analyzed using Kaplan-Meier estimates. Cox regression was applied to construct two models: Model 1 (Outpatient Clinical Predictive Model, OCPM) based on clinical variables, and Model 2 (Comprehensive Inpatient Predictive Model, CIPM) incorporating imaging and urine culture. Nomograms were established, and model performance was assessed using time-dependent ROC curves, calibration curves, and 10-fold cross-validation. Clinical utility was evaluated by decision curve analysis and clinical impact curves.
Results
Stone-free rates (SFRs) and complication rates (CRs) were comparable between groups, but Uyghur children had a higher recurrence rate (25.2% vs. 13.9%, HR = 2.31, 95% CI: 1.30–4.10). Model 1 (OCPM, age, ethnicity, urine pH, serum creatinine) showed good discrimination for outpatient screening (AUC 0.79–0.85), while Model 2 (CIPM, adding stone size, laterality, multiplicity, and hydronephrosis) achieved superior accuracy (AUC >0.90) and calibration at higher risk levels.
Conclusion
PCNL is effective and safe in both ethnic groups, but Uyghur patients have a higher recurrence risk. The predictive models provide valuable tools for optimizing postoperative management and follow-up strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Institute of Urology, Beijing Municipal Health Commission, Beijing, China.
- Department of Urology, First People's Hospital of Kashgar, Kashgar, China.
- Xinjiang Key Laboratory of Artificial Intelligence Assisted Imaging Diagnosis, Kashgar, China.
- Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China, 776308874@qq.com.
- Institute of Urology, Beijing Municipal Health Commission, Beijing, China, 776308874@qq.com.
Zitieren
APA
Yue, R., Zhang, S., Islam, K., Batur, J., Zhao, Y., Wang, X., & Li, J. (2025). Efficacy, Safety, and Recurrence Prediction of Minimally Invasive Percutaneous Nephrolithotomy in Uyghur and Han Pediatric Patients with Upper Urinary Tract Calculi. Urologia Internationalis. https://doi.org/10.1159/000548385
Vancouver
Yue R, Zhang S, Islam K, Batur J, Zhao Y, Wang X, et al. Efficacy, Safety, and Recurrence Prediction of Minimally Invasive Percutaneous Nephrolithotomy in Uyghur and Han Pediatric Patients with Upper Urinary Tract Calculi. Urologia Internationalis. 2025. doi:10.1159/000548385
BibTeX
@article{Yue2025,
author = {Yue, Ruiyu and Zhang, Shao and Islam, Kahriman and Batur, Jesur and Zhao, Youquan and Wang, Xiaochuan and Li, Jun},
title = {Efficacy, Safety, and Recurrence Prediction of Minimally Invasive Percutaneous Nephrolithotomy in Uyghur and Han Pediatric Patients with Upper Urinary Tract Calculi},
journal = {Urologia Internationalis},
year = {2025},
doi = {10.1159/000548385}
}
EUVIMED